Share News for Gw Pharmaceuticals (GWP)
LONDON, May 20 (Reuters) - A pioneering cannabis-based medicine for multiple sclerosis from GW Pharmaceuticals has been filed for approval in Eu
[20 May '09]
LONDON, May 20 (Reuters) - A pioneering cannabis-based medicine for multiple sclerosis from GW Pharmaceuticals has been filed for approval in Eu
[20 May '09]
STOCKS NEWS Reuters Results diary
Stocks on the move Real-time Equity News
09
[1 Apr '09]
STOCKS NEWS Reuters Results diary
Europe Real-time Equity News
UK
[1 Apr '09]
LONDON, April 1 (Reuters) - GW Pharmaceuticals Plc:
* Has received confirmation from its licensing partner, laboratorios Almirall
th
[1 Apr '09]
By Ben Deighton and Ben Hirschler
LONDON, March 11 (Reuters) - A pioneering cannabis-based medicine from GW Pharmaceuticals has produced po
[11 Mar '09]
LONDON, March 11 (Reuters) - Britain's GW Pharmaceuticals announced on Wednesday positive Phase III results for its cannabis-based Sativex drug
[11 Mar '09]
LONDON, March 11 (Reuters) - GW Pharmaceuticals has announced positive Phase III results for its cannabis-based Sativex drug, clearing the way f
[11 Mar '09]